Scripts and testing don’t require visits to the doc thanks to this partnership between Texas Health Action and the telemedicine portals.

A clinical trial compared injectable cabotegravir given every eight weeks versus daily Truvada for HIV prevention.

Black queer men of MOBI talk about it all—including OnlyFans, HIV and adult films—in this artful digital video series.

A survey of local health departments reveals concerning news—and a silver lining.

As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.

The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.

More than 230,000 women and girls have been diagnosed with HIV in the United States; this year’s theme focuses on prevention.

Researchers examined increasing use of PrEP, expanding access to opioid use disorder treatment and improving engagement with HIV care.

Older women can also benefit from PrEP.

But it comes with deep cuts to Medicare, Medicaid, Social Security, cancer funds and other health and science programs.